Savitz A - Search Results

1

Relationship between antipsychotic blood levels and treatment failure during the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.

Melkote R, Singh A, Vermeulen A, Remmerie B, Savitz A. Melkote R, et al. Among authors: savitz a. Schizophr Res. 2018 Nov;201:324-328. doi: 10.1016/j.schres.2018.05.028. Epub 2018 May 24. Schizophr Res. 2018. PMID: 29804929 Free article. Clinical Trial.

2

Optimizing Antipsychotic Patient Management Using Population Pharmacokinetic Models and Point-of-Care Testing.

Green B, Korell J, Remmerie B, Savitz A, Vermeulen A. Green B, et al. Among authors: savitz a. CPT Pharmacometrics Syst Pharmacol. 2017 Sep;6(9):573-575. doi: 10.1002/psp4.12212. Epub 2017 Jul 13. CPT Pharmacometrics Syst Pharmacol. 2017. PMID: 28575540 Free PMC article.

3

Use of antipsychotic blood levels in clinician decision making: A cross-over study using clinical vignettes of patients with schizophrenia.

Savitz A, Melkote R, Riley R, Pobre MA, McQuarrie K, Williamson D, Banderas B. Savitz A, et al. Psychiatry Res. 2018 Sep;267:25-29. doi: 10.1016/j.psychres.2018.05.014. Epub 2018 May 19. Psychiatry Res. 2018. PMID: 29879602 Free article.

4

Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia: A Randomized Clinical Trial.

Berwaerts J, Liu Y, Gopal S, Nuamah I, Xu H, Savitz A, Coppola D, Schotte A, Remmerie B, Maruta N, Hough DW. Berwaerts J, et al. Among authors: savitz a. JAMA Psychiatry. 2015 Aug;72(8):830-9. doi: 10.1001/jamapsychiatry.2015.0241. JAMA Psychiatry. 2015. PMID: 25820612 Clinical Trial.

5

Pharmacokinetics, safety, and tolerability of paliperidone palmitate 3-month formulation in patients with schizophrenia: A phase-1, single-dose, randomized, open-label study.

Ravenstijn P, Remmerie B, Savitz A, Samtani MN, Nuamah I, Chang CT, De Meulder M, Hough D, Gopal S. Ravenstijn P, et al. Among authors: savitz a. J Clin Pharmacol. 2016 Mar;56(3):330-9. doi: 10.1002/jcph.597. Epub 2015 Oct 5. J Clin Pharmacol. 2016. PMID: 26189570 Clinical Trial.

6

Prospective dose selection and acceleration of paliperidone palmitate 3-month formulation development using a pharmacometric bridging strategy.

Samtani MN, Nandy P, Ravenstijn P, Remmerie B, Vermeulen A, Russu A, D'hoore P, Baum EZ, Savitz A, Gopal S, Hough D. Samtani MN, et al. Among authors: savitz a. Br J Clin Pharmacol. 2016 Nov;82(5):1364-1370. doi: 10.1111/bcp.13050. Epub 2016 Jul 24. Br J Clin Pharmacol. 2016. PMID: 27333588 Free PMC article. Clinical Trial.

7

Comparison of Capillary and Venous Plasma Drug Concentrations After Repeated Administration of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole.

Remmerie B, De Meulder M, Ariyawansa J, Savitz A. Remmerie B, et al. Among authors: savitz a. Clin Pharmacol Drug Dev. 2016 Nov;5(6):538-547. doi: 10.1002/cpdd.291. Epub 2016 Aug 17. Clin Pharmacol Drug Dev. 2016. PMID: 27363344 Free PMC article.

8

Comparison of Capillary and Venous Drug Concentrations After Administration of a Single Dose of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole.

Remmerie B, De Meulder M, Weiner S, Savitz A. Remmerie B, et al. Among authors: savitz a. Clin Pharmacol Drug Dev. 2016 Nov;5(6):528-537. doi: 10.1002/cpdd.290. Epub 2016 Sep 28. Clin Pharmacol Drug Dev. 2016. PMID: 27365164 Free PMC article. Clinical Trial.

9

Practical guidance for dosing and switching from paliperidone palmitate 1 monthly to 3 monthly formulation in schizophrenia.

Gopal S, Vermeulen A, Nandy P, Ravenstijn P, Nuamah I, Buron Vidal JA, Berwaerts J, Savitz A, Hough D, Samtani MN. Gopal S, et al. Among authors: savitz a. Curr Med Res Opin. 2015 Nov;31(11):2043-54. doi: 10.1185/03007995.2015.1085849. Epub 2015 Oct 2. Curr Med Res Opin. 2015. PMID: 26306819

10

Comparison of Relapse Prevention with 3 Different Paliperidone Formulations in Patients with Schizophrenia Continuing versus Discontinuing Active Antipsychotic Treatment: A Post-Hoc Analysis of 3 Similarly Designed Randomized Studies.

Mathews M, Gopal S, Singh A, Nuamah I, Pungor K, Tan W, Soares B, Kim E, Savitz AJ. Mathews M, et al. Among authors: savitz aj. Neuropsychiatr Dis Treat. 2020 Jun 19;16:1533-1542. doi: 10.2147/NDT.S221242. eCollection 2020. Neuropsychiatr Dis Treat. 2020. PMID: 32606705 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters